Meeder Asset Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.95K | Buy |
107
+25
| +30% | +$690 | ﹤0.01% | 779 |
|
|
2025
Q1 | $2.33K | Sell |
82
-30
| -27% | -$851 | ﹤0.01% | 858 |
|
|
2024
Q4 | $4.66K | Buy |
112
+12
| +12% | +$499 | ﹤0.01% | 841 |
|
|
2024
Q3 | $6.68K | Buy |
100
+8
| +9% | +$535 | ﹤0.01% | 696 |
|
|
2024
Q2 | $10.9K | Sell |
92
-6
| -6% | -$713 | ﹤0.01% | 632 |
|
|
2024
Q1 | $10.4K | Buy |
+98
| New | +$10.4K | ﹤0.01% | 544 |
|
|
2023
Q1 | – | Sell |
-29,802
| Closed | -$5.35M | – | 758 |
|
|
2022
Q4 | $5.35M | Sell |
29,802
-9,357
| -24% | -$1.68M | 0.47% | 46 |
|
|
2022
Q3 | $4.63M | Buy |
39,159
+9,986
| +34% | +$1.18M | 0.27% | 75 |
|
|
2022
Q2 | $4.17M | Buy |
29,173
+6,268
| +27% | +$895K | 0.24% | 81 |
|
|
2022
Q1 | $3.95M | Buy |
+22,905
| New | +$3.95M | 0.19% | 97 |
|
|
2021
Q4 | – | Sell |
-11,360
| Closed | -$4.37M | – | 1890 |
|
|
2021
Q3 | $4.37M | Sell |
11,360
-15,016
| -57% | -$5.78M | 0.23% | 96 |
|
|
2021
Q2 | $6.2M | Buy |
26,376
+1,437
| +6% | +$338K | 0.29% | 78 |
|
|
2021
Q1 | $3.27M | Buy |
24,939
+24,069
| +2,767% | +$3.15M | 0.17% | 125 |
|
|
2020
Q4 | $91K | Sell |
870
-10,231
| -92% | -$1.07M | 0.02% | 437 |
|
|
2020
Q3 | $785K | Buy |
11,101
+367
| +3% | +$26K | 0.05% | 276 |
|
|
2020
Q2 | $690K | Sell |
10,734
-2,924
| -21% | -$188K | 0.04% | 305 |
|
|
2020
Q1 | $409K | Buy |
13,658
+13,531
| +10,654% | +$405K | 0.03% | 384 |
|
|
2019
Q4 | $2K | Buy |
127
+7
| +6% | +$110 | ﹤0.01% | 2028 |
|
|
2019
Q3 | $2K | Buy |
+120
| New | +$2K | ﹤0.01% | 1968 |
|